Medicare Enrolled

Dr. David Engler

Allergy Physician · Houston, TX
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
7707 FANNIN ST STE 100, Houston, TX 77054
7137970993
In practice since 2005 (20 years)
NPI: 1669477568 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Engler from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Engler? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Engler

Dr. David Engler is an allergy physician in Houston, TX, with 20 years in practice. Based on federal Medicare data, Dr. Engler performed 21,924 Medicare services across 1,016 unique beneficiaries.

Between the years covered by Open Payments, Dr. Engler received a total of $17,680 from 33 pharmaceutical and/or device companies across 596 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in allergy physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Engler is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice▲ Top 2% volume in TX$ $17,680 industry payments

Medicare Practice Summary

Medicare Utilization ↗
21,924
Medicare services
Top 2% in TX for allergy physician
1,016
Unique beneficiaries
$21
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~1,096 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Omalizumab injection (Xolair) for asthma/allergy10,830$30$56
Allergy skin test3,040$3$13
Allergy immunotherapy preparation1,990$12$22
Professional service for preparation and provision of single-dose vial of allergen1,550$14$22
Test for allergy using allergenic extract injected into skin1,340$7$13
Allergy injection therapy, multiple injections1,035$9$34
Drug injection, under skin or into muscle610$11$38
Test to measure rate of airflow230$30$105
Test to measure the level of nitric oxide gas207$15$35
Office visit, established patient (30-39 min)196$97$216
Ceftriaxone antibiotic injection172$0$15
Administration and interpretation of patient-focused health risk assessment147$2$12
Betamethasone steroid injection118$4$31
Office visit, established patient (20-29 min)85$68$143
Injection, methylprednisolone acetate, 80 mg76$8$31
Injection, adrenalin, epinephrine, 0.1 mg70$1$22
Injection, diphenhydramine hcl, up to 50 mg67$1$25
Evaluation of use of breathing device48$13$35
New patient office visit (45-59 min)45$133$249
Office visit, established patient, complex (40-54 min)30$148$294
Office visit, established patient (10-19 min)20$44$98
Test to assess middle ear function18$13$44
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$17,680
Total received (2018-2024)
Avg $2,526/year across 7 years
Top 7% in TX for allergy physician
33
Companies
596
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$12,156 (68.8%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$3,698 (20.9%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$1,827 (10.3%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$2,382
2023
$1,980
2022
$1,959
2021
$1,946
2020
$1,117
2019
$1,497
2018
$6,798

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Genentech USA, Inc.
$4,253
AstraZeneca Pharmaceuticals LP
$1,680
ALK-Abello, Inc
$1,665
GlaxoSmithKline, LLC.
$1,380
CSL Behring
$1,295
Takeda Pharmaceuticals U.S.A., Inc.
$1,103
BioCryst US Sales Co., LLC
$791
Grifols USA, LLC
$679
Novartis Pharmaceuticals Corporation
$624
GENZYME CORPORATION
$603
Shire North American Group Inc
$549
PFIZER INC.
$548
Regeneron Healthcare Solutions, Inc.
$409
kaleo, Inc.
$324
Blueprint Medicines Corporation
$271
Amgen Inc.
$270
Boehringer Ingelheim Pharmaceuticals, Inc.
$222
LEO Pharma Inc.
$174
Mylan Specialty L.P.
$128
Octapharma USA, Inc.
$97
Pharming Healthcare, Inc.
$95
HOSPIRA, INC.
$88
Sunovion Pharmaceuticals Inc.
$88
Phadia US Inc.
$85
Teva Pharmaceuticals USA, Inc.
$55
SANOFI-AVENTIS U.S. LLC
$43
BioCryst Pharmaceuticals, Inc.
$41
Incyte Corporation
$22
Optinose US, Inc.
$22
AIMMUNE THERAPEUTICS, INC.
$20
Horizon Pharma plc
$19
ADMA BioManufacturing LLC
$19
Kaleo, Inc.
$17
Top 3 companies account for 43.0% of total payments
Associated products mentioned in payments ›
ACTIMMUNE · ADBRY · AIRSUPRA · AREXVY · AUVI-Q · AYVAKIT · AirDuo Digihaler · BREO · BREO ELLIPTA · BREZTRI · BREZTRI AEROSPHERE · BROVANA · CIBINQO · CUTAQUIG · CUVITRU · DUPIXENT · DUPIXENT DUPILUMAB INJECTION · EUCRISA · FASENRA · FIRAZYR · GAVRETO · Gamunex-C · Grastek · HYQVIA · Haegarda · Hizentra · ImmunoCAP · LONHALA MAGNAIR · NUCALA · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OPZELURA · ORLADEYO · Odactra · Orladeyo · PALFORZIA · PANZYGA · PREVNAR 20 · ProAir Digihaler · RUCONEST · SPIRIVA · SPIRIVA RESPIMAT · STIOLTO RESPIMAT · SYMBICORT · TAKHZYRO · TEZSPIRE · TRELEGY ELLIPTA · XOLAIR · Xembify · Xhance · Xolair · YUPELRI · Yupelri
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (69%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 7% for allergy physician in TX.

Equivalent to $81 per 100 Medicare services performed
Looking for a allergy physician in Houston?
Compare allergy physicians in the Houston area by procedure volume, costs, and industry payment transparency.
Browse allergy physicians nearby

Geographic Context

Allergy Physicians within 10 mi
18
Per 100K population
0.4
County median income
$73,104
Nearest hospital
WOMANS HOSPITAL OF TEXAS,THE
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Engler is a mixed practice specialist, with above-average Medicare volume (top 2% in TX), and high industry engagement (low-engagement, top 7%), with 20 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Engler experienced with omalizumab injection (xolair) for asthma/allergy?
Based on Medicare claims data, Dr. Engler performed 10,830 omalizumab injection (xolair) for asthma/allergy services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Engler receive payments from pharmaceutical companies?
Yes. Dr. Engler received a total of $17,680 from 33 companies across 596 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Engler's costs compare to other allergy physicians in Houston?
Dr. Engler's average Medicare payment per service is $21. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Engler) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →